CN103472229B - 一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 - Google Patents
一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 Download PDFInfo
- Publication number
- CN103472229B CN103472229B CN201310428782.4A CN201310428782A CN103472229B CN 103472229 B CN103472229 B CN 103472229B CN 201310428782 A CN201310428782 A CN 201310428782A CN 103472229 B CN103472229 B CN 103472229B
- Authority
- CN
- China
- Prior art keywords
- magnetic bead
- solution
- carcinomebryonic antigen
- antigen
- detection kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 79
- 102000036639 antigens Human genes 0.000 title claims abstract description 70
- 108091007433 antigens Proteins 0.000 title claims abstract description 70
- 238000001514 detection method Methods 0.000 title claims abstract description 47
- 238000003556 assay Methods 0.000 title claims abstract description 17
- 239000011859 microparticle Substances 0.000 title claims abstract description 17
- 239000011324 bead Substances 0.000 claims abstract description 117
- 238000004140 cleaning Methods 0.000 claims abstract description 32
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 12
- 239000000758 substrate Substances 0.000 claims abstract description 12
- 238000002372 labelling Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 75
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 238000013016 damping Methods 0.000 claims description 35
- 239000012530 fluid Substances 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 27
- 210000002966 serum Anatomy 0.000 claims description 18
- 239000007853 buffer solution Substances 0.000 claims description 16
- 239000006185 dispersion Substances 0.000 claims description 15
- 239000007987 MES buffer Substances 0.000 claims description 14
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229940088597 hormone Drugs 0.000 claims description 9
- 239000005556 hormone Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 239000008366 buffered solution Substances 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000007974 sodium acetate buffer Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 108010058846 Ovalbumin Proteins 0.000 claims description 3
- GHXRKGHKMRZBJH-UHFFFAOYSA-N boric acid Chemical compound OB(O)O.OB(O)O GHXRKGHKMRZBJH-UHFFFAOYSA-N 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 3
- 229940092253 ovalbumin Drugs 0.000 claims description 3
- 235000020183 skimmed milk Nutrition 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 11
- 206010028980 Neoplasm Diseases 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 21
- 238000002038 chemiluminescence detection Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000006249 magnetic particle Substances 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000003547 immunosorbent Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- MNMDQPHROBCYHZ-UHFFFAOYSA-L [Na+].[Na+].O.[PH2](=O)[O-].[PH2](=O)[O-] Chemical compound [Na+].[Na+].O.[PH2](=O)[O-].[PH2](=O)[O-] MNMDQPHROBCYHZ-UHFFFAOYSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- DGLRDKLJZLEJCY-UHFFFAOYSA-L disodium hydrogenphosphate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O DGLRDKLJZLEJCY-UHFFFAOYSA-L 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
检验项目 | 检验标准 | 检验结果 |
准确性 | 平均回收率在90.0-110.0% | 符合标准 |
特异性 | 与其类似物的交叉反应率≤0.01% | 符合标准 |
精密度CV(%) | ≤10%(n=10) | 符合标准 |
灵敏度 | ≤1.00pg/mL | 符合标准 |
稳定性 | 各试剂组分置37℃至少3天 | 符合标准 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310428782.4A CN103472229B (zh) | 2013-09-17 | 2013-09-17 | 一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310428782.4A CN103472229B (zh) | 2013-09-17 | 2013-09-17 | 一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103472229A CN103472229A (zh) | 2013-12-25 |
CN103472229B true CN103472229B (zh) | 2016-01-13 |
Family
ID=49797156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310428782.4A Active CN103472229B (zh) | 2013-09-17 | 2013-09-17 | 一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103472229B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104089949A (zh) * | 2014-06-27 | 2014-10-08 | 江苏福隆生物技术有限公司 | 胃泌素释放肽前体定量测定试剂盒、其制备方法及检测方法 |
CN104698185B (zh) * | 2015-02-10 | 2016-08-31 | 深圳市新产业生物医学工程股份有限公司 | 检测梅毒螺旋体抗体的试剂盒及其检测方法和应用 |
CN105136782A (zh) * | 2015-09-15 | 2015-12-09 | 安徽博睿生物科技有限公司 | 一种免疫磁微粒化学发光法hcmv ie1抗原检测试剂盒 |
CN106556699B (zh) * | 2015-09-30 | 2021-05-07 | 宁波紫园医疗器械有限公司 | 用于测定豆荚蛋白的血液水平的方法和组合物 |
CN105548549B (zh) * | 2015-12-08 | 2016-09-21 | 孙丽华 | 癌胚抗原(cea)定量检测试剂盒及其制备方法 |
CN108872595A (zh) * | 2018-07-05 | 2018-11-23 | 潍坊市康华生物技术有限公司 | 一种癌胚抗原检测试剂盒及其制备方法 |
CN113514448A (zh) * | 2018-09-25 | 2021-10-19 | 无锡壹闪生物科技有限公司 | 空间邻近化学发光法检测d-二聚体的试剂盒的应用 |
CN109142337A (zh) * | 2018-09-25 | 2019-01-04 | 无锡壹闪生物科技有限公司 | 空间邻近化学发光法检测血清淀粉样蛋白a的试剂盒及其检测方法 |
CN109374884B (zh) * | 2018-12-24 | 2021-10-22 | 四川沃文特生物技术有限公司 | 一种pct浓度检测试剂盒及其制备方法 |
CN109781986B (zh) * | 2019-03-11 | 2022-03-25 | 复旦大学附属妇产科医院 | 一种磁微粒化学发光免疫检测CA125表面Tn抗原的试剂盒及其制备方法 |
CN110850076A (zh) * | 2019-11-28 | 2020-02-28 | 南京迪安医学检验所有限公司 | 一种抗双链DNA抗体IgG化学发光免疫测定试剂盒及其制备方法和应用 |
CN112630430B (zh) * | 2020-11-16 | 2021-08-27 | 北京美联泰科生物技术有限公司 | 一种定量检测uchl-1的试剂盒及其应用 |
CN113655217A (zh) * | 2021-08-19 | 2021-11-16 | 四川沃文特生物技术有限公司 | 磁珠、试剂盒、制备方法及用途 |
CN114113589A (zh) * | 2021-10-25 | 2022-03-01 | 江苏纳迪芯生命科技研究院有限公司 | 一种基于磁微粒发光法的沙眼衣原体和解脲支原体抗原检测试剂盒 |
CN116429753B (zh) * | 2023-02-13 | 2024-07-19 | 科美博阳诊断技术(上海)有限公司 | Cea检测试剂盒及其使用方法 |
CN116482369B (zh) * | 2023-06-13 | 2023-08-25 | 天津市协和医药科技集团有限公司 | 一种癌胚抗原检测试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101762700A (zh) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 |
CN101776683A (zh) * | 2010-01-06 | 2010-07-14 | 东华大学 | 基于荧光纳米发光和磁性纳米材料的癌胚抗原的检测方法 |
CN102426257A (zh) * | 2011-08-16 | 2012-04-25 | 内蒙古科慧生物科技有限责任公司 | 癌胚抗原(cea)定量测定试剂盒及其检测方法 |
CN102507947A (zh) * | 2011-11-11 | 2012-06-20 | 南方医科大学 | 一种基于免疫磁珠的cea时间分辨荧光免疫分析试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2931111B2 (ja) * | 1990-12-28 | 1999-08-09 | 三井化学株式会社 | 癌診断剤 |
-
2013
- 2013-09-17 CN CN201310428782.4A patent/CN103472229B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101762700A (zh) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 |
CN101776683A (zh) * | 2010-01-06 | 2010-07-14 | 东华大学 | 基于荧光纳米发光和磁性纳米材料的癌胚抗原的检测方法 |
CN102426257A (zh) * | 2011-08-16 | 2012-04-25 | 内蒙古科慧生物科技有限责任公司 | 癌胚抗原(cea)定量测定试剂盒及其检测方法 |
CN102507947A (zh) * | 2011-11-11 | 2012-06-20 | 南方医科大学 | 一种基于免疫磁珠的cea时间分辨荧光免疫分析试剂盒 |
Non-Patent Citations (2)
Title |
---|
Stable and general-purpose chemiluminescent detection system for horseradish peroxidase employing a thiazole compound enhancer and some additives;Riko Iwata 等;《Analytical Biochemistry》;19951031;第231卷(第1期);171页右栏第2段,图1-5 * |
增强化学发光酶联免疫分析新体系的研究及应用;司梦军;《万方数据库 青岛科技大学硕士学位论文》;20090331;第5.2.2.1节 * |
Also Published As
Publication number | Publication date |
---|---|
CN103472229A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103472229B (zh) | 一种癌胚抗原磁微粒化学发光免疫分析检测试剂盒 | |
CN103389381B (zh) | 附睾蛋白4化学发光检测试剂盒及其制备方法 | |
CN102759631B (zh) | 一种定量检测降钙素原pct的胶乳增强免疫比浊试剂盒 | |
CN102507947B (zh) | 一种基于免疫磁珠的cea时间分辨荧光免疫分析试剂盒 | |
CN103134934B (zh) | 可以同时检测尿液和血清样本中视黄醇结合蛋白的试剂盒 | |
CN104237525B (zh) | 一种用于测定降钙素原的胶乳增强免疫比浊试剂盒及其制备方法和应用 | |
CN107543932A (zh) | 一种降钙素的磁微粒化学发光检测试剂盒及制备方法 | |
Yu et al. | Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma | |
CN102998445B (zh) | 一种测定甘胆酸的试剂及制备方法 | |
CN103364558A (zh) | 一种人肿瘤标志物癌胚抗原(cea)的磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN104316683B (zh) | 针对全血的卵巢癌细胞检测试剂盒 | |
CN105352958A (zh) | 总25-羟基维生素d检测试剂盒 | |
CN101368966A (zh) | 一种胃泌素释放肽前体化学发光免疫分析测定试剂盒 | |
JPS6367864B2 (zh) | ||
CN105203748A (zh) | 一种全量程c反应蛋白的定量检测试剂盒 | |
WO2021088730A1 (zh) | 游离前列腺特异性抗原检测试剂盒及其制备方法 | |
CN101762700A (zh) | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 | |
CN202916286U (zh) | 一种定量检测降钙素原pct的胶乳增强免疫比浊试剂盒 | |
CN103323596A (zh) | 髓过氧化物酶含量检测试剂盒及其制备方法 | |
CN106546750A (zh) | 一种微量白蛋白快速定量检测试纸条的制备及检测方法 | |
CN108593940B (zh) | 一种尿液转铁蛋白检测试剂盒 | |
CN103048453B (zh) | 一种糖类抗原ca19-9的纳米磁微粒化学发光测定试剂盒及其制备方法和检测方法 | |
CN104849443B (zh) | 基于pH计的酶联免疫吸附测定方法 | |
CN205910194U (zh) | 一种同步联合定量检测不同分子形式人中性粒细胞脂质运载蛋白的免疫层析装置 | |
Tecles et al. | Validation of a commercially available human immunoturbidimetric assay for haptoglobin determination in canine serum samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 430223 B11 building, No. 818, hi tech medical center, hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, 2 Patentee after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Address before: 430223 Hubei city of Wuhan province East Lake Development Zone Road, University of Wuhan University of science and Technology Park building four floor Patentee before: Wuhan Life Origin Biotech Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Magnetic particle chemiluminescence immune assay detection kit for carcino-embryonic antigen and detection method of detection kit Effective date of registration: 20180612 Granted publication date: 20160113 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190620 Granted publication date: 20160113 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Magnetic particle chemiluminescence immune assay detection kit for carcino-embryonic antigen and detection method of detection kit Effective date of registration: 20191107 Granted publication date: 20160113 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co., Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: Y2019420000025 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201223 Granted publication date: 20160113 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Registration number: Y2019420000025 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |